Detirelix is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) studied in laboratory research as a GnRH receptor antagonist tool compound in vitro. This article summarizes its structure and how researchers characterize it in controlled laboratory settings only.

Structure: Detirelix carries multiple D-amino acid substitutions and a modified C-terminus relative to native GnRH. Those substitutions are studied for their effect on receptor binding and resistance to enzymatic degradation in assay systems. Researchers confirm identity and purity by HPLC and mass spectrometry and review the lot-matched Certificate of Analysis before use in experiments.

Laboratory applications: In cell culture and receptor-binding assays, detirelix is used to probe GnRH receptor signaling, including competitive binding studies and downstream second-messenger readouts in controlled systems. Study designs typically include vehicle controls, a reference antagonist, and analytical verification of the test article. No conclusions about human use can be drawn from in vitro work.

Analytical notes: Store lyophilized material as directed on the product label, protect from moisture, and document lot numbers in laboratory records.

Disclaimer: This product and this article are for laboratory research purposes only. Not for human consumption. Not for medical, therapeutic, diagnostic, or veterinary use. No dosing, reconstitution-for-use, or efficacy information is provided or implied.

Citations: GnRH receptor pharmacology reviews; standard HPLC/MS peptide characterization methods.